BAVENCIO (avelumab)

**Product type:** Human Prescription Drug

**Active ingredient:** AVELUMAB

**Strength:** 20 mg/mL

**Dosage form:** Injection, Solution, Concentrate

**Route:** Intravenous

**Labeler:** EMD Serono, Inc.

**Marketing category:** BLA (BLA761049)

**Pharmacologic class:** Antibodies, Monoclonal [CS], Programmed Death Ligand-1 Antagonists [MoA], Programmed Death Ligand-1 Blocker [EPC], Programmed Death Ligand-1-directed Antibody Interactions [MoA]